Magnetic Ventures — Full Portfolio

Relation RX is a biotech company focused on discovering novel medicines through an interdisciplinary approach combining expertise from technology, pharma, academia, and venture.

AI & Machine LearningBiotechDeep TechMiami Beach, US

DRDavid Roblin(Chief Executive Officer)inCasey Benjamin Swerner(Executive Officer)inBenjamin Swerner(Founder)Charles Roberts(Founder)Jake Taylor-King(Founder)

BoardJason Pontin(Director)

Board seatCAChristine Aylward· per SEC Form D

Co-investorsDCDCVC (Data Collective)HIHitachi VenturesRARaptor GroupDEDeerfield Management CompanyKHKhosla VenturesNVNVentures

AppliedVR develops immersive therapeutic software using technology to deliver drug-free clinical treatments for patients.

Digital HealthHealthtechMedical DevicesLos Angeles, US

MSMatthew Stoudt(Co-Founder and CEO)inJSJosh Sackman(Co-Founder and President)in

BoardDavid Sackman(Chairman)

Co-investorsENEntrada VenturesF-F-Prime CapitalJAJAZZ Venture PartnersPRPresence CapitalTETechstarsGSGSR Ventures+1 more

Deep Genomics develops AI-based biological foundation models to identify drug targets and design molecules, aiming to speed up drug discovery.

AI & Machine LearningBiotechDeep TechToronto, CA

BFBrendan Frey(Founder)inBOBrian O'Callaghan(Chief Executive Officer)inDJDavid Johnston(Chief Financial Officer)inCBClive Bertram(Chief Business Officer)inTMTom Masterson(Chief Operating Officer)inGHGreg Hoffman(Chief Scientific Officer)in

Co-investors1111.2 CapitalBLBloomberg BetaFUFuture VenturesKEKensington Capital Partners LimitedSOSoftBank Vision FundTRTrue Ventures+2 more

Eclipsebio provides RNA biology analytical services and sequencing-based assays that help drug developers and researchers characterize RNA at nucleotide-level resolution and generate datasets for AI-driven drug discovery.

AI & Machine LearningBiotechDeep TechSan Diego, US

EYEugene Yeo(Director)PCPeter Chu(Executive Officer, Director)inEric L Van Nostrand(Director)Hallie Kuhn(Director)

BoardEWEdmond Wong(Director)inDaniel Vasella(Director)

Co-investorsBRBrainstorm VenturesIGiGlobe PartnersPHPhoenix Venture Partners

Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.

AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US

JSJonathan Sporn(Founder)inAKAndrew Kruegel(Founder)inDSDalibor Sames(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Thomas Kevin Murphy, Ph.D.(Executive Officer)JSJONATHAN SPORN(Founder)in

Co-investorsAEAera VCALAlumni VenturesAWAwareness VentureFRFrontera Technology VenturesFRFrontier Path VCGAGaingels+27 more

GroundGame.Health operates a technology platform and hyperlocal operating model that connects health plans, providers, employers, and community-based organizations to address barriers to care and social determinants of health.

Digital HealthHealthtechImpact & Social GoodSocialTampa, US

SRSusan Rawlings Molina(Executive Officer, Director, Promoter)inSridhar Akula(Executive Officer, Director)Aimee Dailey(Director)

BoardRGRobert Garber(Director)inShantanu Agrawal(Director)Jennifer Jarrell(Director)

Co-investors7W7wire VenturesCOCorewell Health VenturesFAFalconX VenturesRARaptor Group

HiberCell develops therapeutic candidates targeting the Integrated Stress Response pathway to address treatment-resistant cancers, relapse, and metastasis.

BiotechMedical Devices

JAJulio Aguirre-Ghiso, Ph.D.(Co-Founder)Steven Gillis, Ph.D.(Chairman & Acting CEO)

Co-investorsARARCH Venture PartnersRARaptor Group6 6 Dimensions CapitalHEHercules Capital, Inc.HIHillhouse Capital

Luminal provides AI model compilation and inference optimization software that compiles models into optimized native code for GPUs and ASICs, delivering 2-3x faster inference performance compared to traditional runtime inference engines.

AI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareSan Francisco, US

JFJoe Fioti(CEO)inMGMatthew Gunton(CTO)inJSJake Stevens(Founder)inJacob Stevens(Executive Officer, Director)

Co-investorsFEFelicis VenturesSASaga VenturesSPSpot VCSTSterling RoadY Y CombinatorA.A.Capital Ventures+19 more

Paradigm Health provides technology and services that integrate with healthcare provider organizations to improve the clinical trial process.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSaaSColumbus, US

KTKent Thoelke(Founder)inJonathan Hirsch(Chief Strategy and Growth Officer)JTJay Trepanier(Chief Financial Officer)inElijah Meerson(Chief Technology Officer)inMLMichelle Lee(Chief Operating Officer)in

Co-investorsARARCH Venture PartnersGEGeneral CatalystGVGV (Google Ventures)LULux CapitalF-F-Prime CapitalJOJobsOhio Ventures+2 more

Prompt is an Ambient AI product and research company that develops human-centered AI products designed to sense the physical environment.

AI & Machine LearningConsumerDeep TechSan Francisco, US

TXTete Xiao(Founder)in

Co-investorsABAbstract VenturesAIAIX VenturesDCDCVC (Data Collective)NENeotribe VenturesALAlexandriaBRBraidwell+4 more

Proxima is a biotech company developing proximity therapeutics through a drug discovery engine and a structural proteomics data platform.

AI & Machine LearningBiotechDeep Tech

JBJonathan Bernardini(Founder)inZCZachary Carpenter(Co-Founder & CEO)inLNLuca Naef(Co-Founder & CTO)in

Co-investorsMOModi VenturesDCDCVC (Data Collective)

Proxima develops AI-powered gaming experiences and infrastructure, with a focus on embodied AI agents and applied AI systems for interactive entertainment.

AI & Machine LearningGamingSan Francisco, US

Ran Mo(Founder)in

Co-investorsAIAIX VenturesKOKonvoy VenturesPRProgressionALAlexandriaBABalderton CapitalBABayern Kapital+9 more

Resilience is a contract development and manufacturing organization (CDMO) that manufactures complex pharmaceutical products and active pharmaceutical ingredients to broaden access to medicines and protect biopharmaceutical supply chains against disruption.

Advanced ManufacturingBiotechEnterprise SoftwareBlue Ash, US

William S. Marth(Chief Executive Officer)William S. Marth, RPh., MBA(President & CEO)

BoardRNRobert Nelsen(Chairman, Resilience; Founder, ARCH)

Co-investors8V8VCARARCH Venture PartnersCACatalio Capital Management, LPGLGlobal Health Investment CorporationGVGV (Google Ventures)JIJIMCO+15 more

GroundGame.Health connects health plans, providers, employers, and community-based organizations with care coordinators who address social needs and barriers to care through local, culturally tailored human interactions.

Digital HealthHealthtechImpact & Social Good

Co-investors7W7wire VenturesCOCorewell Health VenturesRARaptor Group

HealthtechSan Francisco, US

ALEXANDER MARSON(Executive Officer, Director)PATRICK DAVID HSU(Director)JACOB CORN(Director)

BoardBBBLAKE BYERS(Director)in

Co-investorsTETeam Builder VenturesGVGV (Google Ventures)

Stipple Bio develops targeted oncology therapies that act on tumor-specific cell surface epitopes to expand druggable targets and improve therapeutic index for cancer patients.

BiotechHealthtechCambridge, US

ARAaron Ring(Co-founder)inAMAashish Manglik(Co-founder)inJeff Landau(Chief Executive Officer)inRGRoland Gendron(Chief Business Officer)inMZMichelle Zhang(Chief Scientific Officer)in

BoardVAVineeta Agarwala(Director)in

Co-investorsRARA CapitalANAndreessen HorowitzGVGV (Google Ventures)OMOMX VenturesAXAxial VCLOLoLa Capital Partners+1 more

Tools company creating key components for next generation treatments

Co-investorsBRBrainstorm VenturesHAHAWKTAILTRTranspose Platform ManagementEXEx Nihilo

Transition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease.

AI & Machine LearningBiotechDeep TechCambridge, US

TKTuomas Knowles(Executive Director, Co-Founder & Chief Technology Officer)SCSamuel Cohen(Executive Director & Co-Founder)inG. Kelly Martin(Executive Chairman & Co-Founder)George Martin(Executive Officer, Director)inStephanie Torruella(Executive Officer)inPreet Makkar(Executive Officer)

Co-investorsNONorthpond VenturesLILifeforce CapitalTATaiho Ventures, LLCDODolby Family Ventures

Triveni Bio develops genetics-informed antibody therapeutics aimed at treating complex immunology and inflammation (I&I) diseases.

BiotechDigital HealthHealthtech

VPVishal Patelin

Co-investorsASAscenta CapitalATAtlas VentureBOBorealis VenturesBOBorealis VenturesOROrbiMedVIViking Global+4 more

Weave Bio builds AI-assisted software for regulatory teams in drug development to author, organize, and manage eCTD submission content across the regulatory lifecycle, covering documents from investigator's brochures and clinical study reports through IND, NDA, and BLA development.

AI & Machine LearningBiotechHealthtechSaaSSan Francisco, US

ACAri Caroline(Chief Strategy Officer)inBRBrandon Rice(Chief Executive Officer)in

Co-investorsFIFirsthandVCGRGround Up VenturesRARaptor GroupTMTMVUSUS Venture PartnersCHCharacter+1 more